Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tolfenpyrad Modulates Antibiotic Activity on <i>Francisella novicida</i> and Synergizes with Electron Transport Chain Inhibitors.

ACS infectious diseases·2026
Same author

Teixobactin: A Resistance-Evading Antibiotic for Treating Anthrax.

ACS infectious diseases·2025
Same author

Evaluation of a potent LpxC inhibitor for post-exposure prophylaxis treatment of antibiotic-resistant <i>Burkholderia pseudomallei</i> in a murine infection model.

Antimicrobial agents and chemotherapy·2024
Same author

Engineered antibodies targeted to bacterial surface integrate effector functions with toxin neutralization to provide superior efficacy against bacterial infections.

medRxiv : the preprint server for health sciences·2024
Same author

Tolfenpyrad Derivatives Exhibit Potent <i>Francisella</i>-Specific Antibacterial Activity without Toxicity to Mammalian Cells <i>In Vitro</i>.

ACS infectious diseases·2024
Same author

Omadacycline is active <i>in vitro</i> and <i>in vivo</i> against ciprofloxacin-resistant <i>Bacillus anthracis</i>.

Antimicrobial agents and chemotherapy·2024
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Dec 5, 2025

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

18.7K

Validated Methods for Removing Select Agent Samples from Biosafety Level 3 Laboratories.

Alexandria E Kesterson, John E Craig, Lara J Chuvala

    Emerging Infectious Diseases
    |October 20, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Researchers validated sterile filtration and methanol treatments to safely remove dangerous select agents like Francisella tularensis and Bacillus anthracis from lab samples. These methods ensure sample integrity during transfers, enhancing biosafety protocols.

    Keywords:
    BSL-3Bacillus anthracisBurkholderia malleiBurkholderia pseudomalleiFrancisella tularensisYersinia pestisbacteriabiosafety level 3filtrationmethanolsample removalselect agentssterilityvalidation

    More Related Videos

    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
    11:13

    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

    Published on: October 3, 2016

    14.9K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K

    Related Experiment Videos

    Last Updated: Dec 5, 2025

    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
    08:53

    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

    Published on: October 3, 2016

    18.7K
    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology
    11:13

    Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 3. Aerobiology

    Published on: October 3, 2016

    14.9K
    Remote Laboratory Management: Respiratory Virus Diagnostics
    14:56

    Remote Laboratory Management: Respiratory Virus Diagnostics

    Published on: April 6, 2019

    33.4K

    Area of Science:

    • Microbiology
    • Biosafety
    • Infectious Disease Research

    Background:

    • The Federal Select Agent Program mandates strict sterilization protocols for biological samples leaving containment.
    • Maintaining sample integrity during decontamination is crucial for continued research.
    • Several high-risk select agents require validated inactivation methods.

    Purpose of the Study:

    • To validate laboratory procedures for the effective removal of select agents from research samples.
    • To confirm that decontamination methods preserve sample integrity for downstream analysis.
    • To ensure compliance with Federal Select Agent Program regulations.

    Main Methods:

    • Validation of sterile filtration techniques for sample decontamination.
    • Application and validation of methanol treatment for inactivating specific select agents.
    • Testing of decontamination efficacy against Francisella tularensis, Burkholderia pseudomallei, B. mallei, Yersinia pestis, and Bacillus anthracis.

    Main Results:

    • Sterile filtration and methanol treatment were confirmed as effective methods for removing target select agents.
    • Methanol treatment efficacy was specifically validated for Burkholderia pseudomallei.
    • Procedures successfully decontaminated samples while maintaining their structural integrity.

    Conclusions:

    • Validated decontamination protocols enhance biosafety for transferring select agents between laboratories.
    • These methods support safe research practices by ensuring sample viability post-treatment.
    • Compliance with regulatory requirements is met through rigorous validation of sterilization techniques.